The importance of progesterone level at day of human chorionic gonadotropin (hCG) administration on pregnancy rate in the short-term protocol

Not Applicable

Recruiting

• Conditions: Women with primary idiopatic infertility or miscarriage; Reproductive Health and Childbirth - Fertility including in vitro fertilisation

• Registration Number: ACTRN12613000082707
• Lead Sponsor: Clinic Center Hera

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-01-22
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 104

Inclusion Criteria

Patients scheduled for IVF-ICSI cycles with an average age of 35 years with basal FSH values <9 mIU/ml and a BMI normal.

Exclusion Criteria

patients with more of 38 years, with basal FSH values >9 mIU/ml and a BMI abnormal.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pregnancy rate.<br>The clinical pregnancy was assessed by the presence of , the clinical pregnancy was assessed by the presence of serum beta-Human chorionic gonadotropin (beta-hCG) positive after 15 days from the oocyte pick up and display of room gestational with or without fetal heartbeat.[At 2 weeks after egg collection for Intracytoplasmic sperm injection (ICSI)]

Secondary Outcome Measures

Name	Time	Method
nil[nil]